RAC will most likely raise the full funds.
Worst case, Even if it it doesn’t, what gets missed out is (AML in Europe, low priority trial)Or RAC might involve instos.
It is low priority because it’s not pathway to registration.
Importantly, all the other important trials FTO, EMD AML and cardio protection Phase2B will be funded and underway.
If you look at timeline from AGM presentation, it seems to end at the last quarter of next year. We can only imagine what that means. Partnership before that, perhaps?
RAC - Charts & Price Action, page-9813
-
- There are more pages in this discussion • 11,776 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |